Kandace P. McGuire, MD

OfficeAddress:West Hospital 7th FloorWest WingBox980011

Richmond, Virginia 23298-0011

OfficePhone:(804)828-9325

Fax:(804)828-4808

Cell:(412)508-9817

Email:

Education:

July2008 –Susan G. Komen/Society of Surgical OncologyFellow

June2009Breast SurgicalOncology

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida

July2007 -Administrative Chief Resident–

June2008Thomas JeffersonUniversityHospitalPhiladelphia,Pennsylvania

June2002–Resident in General Surgery-

June2007Thomas JeffersonUniversityHospitalPhiladelphia,Pennsylvania

July2004 –Research Fellow – Thomas JeffersonUniversity

June2005Philadelphia,Pennsylvania

August1998 -MD – Eastern Virginia MedicalSchool

May2002Norfolk,Virginia

Alpha Omega Alpha

August1994 -BS – Biology University ofRichmond

May1998Richmond,Virginia

Cum laude with honors

Licenses and Certification:

Virginia–0101262560Active North Carolina –2015-01118Active Pennsylvania–MD425523 Inactive Pennsylvania–MT180024 Inactive Florida–TRN12356 Inactive

General Surgery Board Certified 12/10/2008-7/1/2019

Professional Appointments and Positions:

September 2017–PresentAssociate Professor ofSurgery

Virginia Commonwealth University Richmond, VA

September 2017–PresentChief of BreastSurgery

Surgical Leader of the Multidisciplinary Breast Cancer Health Center VCU/Massey Cancer Center

Richmond, VA

July 2015 –August2017Associate Professor ofSurgery

University of North Carolina Chapel Hill, NC

July 2015 –August2017Surgical Director of the Multidisciplinary Breast CancerProgram

Lineberger Comprehensive Cancer Center University of North Carolina

Chapel Hill, NC

July 2009 –June 2015Assistant Professor ofSurgery

University of Pittsburgh Pittsburgh, Pennsylvania

March 2012 –June 2015Program Director of Breast Surgical OncologyFellowship

Magee Womens Hospital, University of Pittsburgh Pittsburgh, Pennsylvania

March 2012 –June 2015Director, Magee Womens Breast Cancer Program,Premenopausal

Services

Magee Womens Hospital, University of Pittsburgh Pittsburgh, Pennsylvania

September 2010–Associate Program Director of Breast SurgicalOncologyFellowshipMarch 2012 Magee Womens Hospital, University ofPittsburgh

Pittsburgh, Pennsylvania

Honors and Awards:

2016UNC ACCLAIM Leadership DevelopmentProgram

2015UNC Surgery “Rookie of the Year Award” for extraordinary service anddedicationtosurgicaleducation

2006-2008Resident Teaching Award for Excellence in Medical Student Education,Thomas JeffersonUniversity, Department ofSurgery

2006Resident Research Award, Academic SurgicalCongress

2005Resident Research Award, Thomas Jefferson University, Departmentof Surgery1998Phi Sigma Iota, Foreign Language Honor Society

1998BetaBetaBeta,BiologyHonorSociety

1998Biology Honors Research Award, UniversityofRichmond1996Golden Key National HonorSociety

Bibliography

Book Chapters:

1.Soran, A., Menekse, E. McGuire, KP. Surgical Management of Operable Breast Cancer After Neoadjuvant Systemic Therapy. In Aydiner, A, Igci, A, Soran, A (ed.): Breast Disease: Diagnosis and Pathology, 1st edition. Springer International Publishing, 375-387,2016.

2.McGuire, KP. Breast Cancer in Young Women (Premenopausal Breast Cancer). In Aydiner,A, Igci, A, Soran, A (ed.): Breast Disease: Diagnosis and Pathology, 1st edition. Springer International Publishing, 375-387,2016.

3.McGuire, KP. Breast Anatomy and Physiology. In Aydiner, A, Igci, A, Soran, A (ed.): Breast Disease: Diagnosis and Pathology, 1st edition. Springer International Publishing, 1-14,2016.

4.McGuire, KP, Cox, CE. Changing Patterns of Surgery for Primary Cancer: Mastectomy Versus Breast Preservation. In DeVita, Jr, VT, Lawrence, TS, Rosenberg, SA (ed.): Principles and Practice of Oncology, 9th edition. Philadelphia: Lippincott Williams & Wilkins, Update Vol 25(5) 2011.

5.Peterson, K, Chojnacki, K: Breast. In Jerrell BE, Carabasi RA III (ed.): The NMS Surgery Text, 5th Edition. Philadelphia: Lippincott Williams & Wilkins,2006.

Peer-Reviewed Publications:

1.Muthuswamy R, Okada NJ, Jenkins FJ, McGuire K, et al. Epinephrine promotes COX-2- dependent immune suppression in myeloid cells and cancer tissues. Brain Behav Immun.2017 May;62:78-86.

2.Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary Management of Breast Cancer during Pregnancy. Oncologist. 2017Mar;22(3):324-224.

3.Soran A, Bhargava R, Johnson R, Ahrendt G, Bonaventura M, Diego E, McAuliffe PF, Serrano M, Menekse E, Sezgin E, McGuire KP. The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer. Breast Dis. 2016 Jul28;36(2-3):65-71.

4.Steiman J, Soran A, McAuliffe P, Diego E, Bonaventura M, Johnson R, Ahrendt G, McGuire K. Predictive value of axillary nodal imaging by magnetic resonance imaging based on breast cancer subtype after neoadjuvant chemotherapy. J Surg Res. 2016Jul;204(1):237-41.

5.Ordu C, McGuire K, Alco G, et al. The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer. Cureus. 2016 Jun 7;8(6):e633.

6.King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, Sing AP, Hwang ES, Alvarado MD, Liu MC, Boughey JC, McGuire KP, et al. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. J Clin Oncol. 2016 Mar 21. J Clin Oncol. 2016 Jul 10; 34(20):2359-65.

7.Diego, EJ, McAuliffe, PF, Soran, A. McGuire, KP, et al. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes. Ann Surg Oncol. 2016May;23(5):1549-53.

8.Merriman, JD, Sereika, SM, Brufsky, AM, McAuliffe, PF, McGuire KP, et al. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer. Psychooncology. 2015 Oct 20. doi: 10.1002/pon.4009. [Epub ahead ofprint].

9.Brown, DD, Dabbs, DJ, Lee AV, McGuire, KP, et al. Developing in vitro models of human ductal carcinoma in situ from primary tissue explants. Breast Cancer Res Treat. 2015 Sep;153(2):311- 21.

10.Liao, S, Hartmaier, RJ, McGuire, KP, et al. The Molecular Landscape of Premenopausal Breast Cancer. Breast Cancer Res. 2015 Aug7;17:104.

11.Boone, BA, Huynh, Cindy, Spangler, ML, Sumkin, J, Johnson, RJ McGuire, KP, Soran, Ahrendt, GM. Axillary Lymph Node Burden in Invasive Breast Cancer: A Comparison of the Predictive Value of Ultrasound Guided Needle Biopsy and Sentinel Lymph Node Biopsy. Clinical Breast Cancer. 2015 Mar; DOI:10.1016/j.clbc.2015.03.011.

12.McGuire, KP, Hwang, ES, Cantor, A, et al. Surgical Patterns of Care Among Academic Institutions in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast MR Imaging: Secondary Analysis of TBCRC 017. Ann Surg Oncol. 2015 Jan; 22(1): 75-81

13.Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014Dec;12(4):289-94.

14.Koleck TA, Bender CM, Sereika SM, Ahrendt G, Jankowitz RC, McGuire KP, et al. Apolipoprotein e genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum. 2014 Nov1;41(6):E313-25.

15.Diego EJ, Soran A, McGuire KP, et al. Localizing High-Risk Lesions for Excisional Breast Biopsy: A Comparison Between Radioactive Seed Localization and Wire Localization. Ann Surg Oncol. 2014 Jul18.

16.Fackler MJ, Bujanda ZL, Umbricht C, Teo WW, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Ingle JN, Boughey J, McGuire K, et al. Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer. Cancer Res April 15, 2014 74;2160.

17.Soran A, Kamali Polat A, Johnson R, McGuire KP. Increasing Trend of Contralateral Prophylactic Mastectomy: What are the factors behind this phenomenon? The Surgeon. 2014 Mar 28. pii: S1479-666X(14)00020-1. doi:10.1016/j.surge.2014.02.005.

18.Hadzikadic Gusic, L, McGuire, KP, Ozmen, T, Soran, A, Diego, EJ, Thomas, CR., McAuliffe, PF, Bonaventura, M, Johnson, RR, Ahrendt, GM. Margin Width is Not Predictive of Residual Disease on Re-excision in Breast Conserving Therapy. Journal of Surgical Oncology. March 2014;109(3).

19.Diego, E, McGuire, KP. A rare case of tumor-to-tumor metastasis: Breast cancer metastatic to a benign renal mass. Journal of Surgical Case Reports, 2013(2):1-4.

20.Jankowitz, RC, McGuire, KP, Davidson, N. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer. The Breast. August 2013; 22(2):S165-170.

21.De Los Santos, J, Cantor, A, McGuire, K et al. Magnetic Resonance Imaging as a Predictor of Pathologic Response in Patients Treated with Neoadjuvant Systemic Treatment for Operable Breast Cancer (TBCRC 017). Cancer. 2013 May 15;119(10):1776-83.

22.Soran A, Ibrahim A, Kanbour M, McGuire, KP, et al. Decision Making and Factors Influencing Long-term Satisfaction With Prophylactic Mastectomy in Women With Breast Cancer. Am J Clin Oncol. May 22013.

23.Kaur P, Santillan AA, McGuire K, Turaga KK, Shamehdi C, Meade T, Ramos D, Mathias M, Parbhoo J, Davis M, Khakpour N, King J, Balducci L, Cox CE. The surgical treatment of breast cancer in the elderly: a single institution comparative review of 5235 patients with 1028patients

≥70 years. Breast J. 2012 Sep; 18(5):428-35.

24.Kraus JA, Beriwal S, Dabbs DJ, Ahrendt GM, McGuire KP, Johnson RR, Badve P, Puhalla SL, Bhargava R. Predictors of Pathologic Complete Response After Standard Neoadjuvant Chemotherapy in Triple-negative Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2012 Jul;20(4):334-9.

25.Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, Bhargava R. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer. Oncology. 2011;80(5-6):341-9.

26.McGuire, KP, Toro-Burguete, J., Dang, H., Young, J., Soran, A., Zuley, M., Bhargava, R., Bonaventura, M., Johnson, R. Ahrendt, G. MRI staging after neoadjuvant chemotherapy for breast cancer: Does tumor biology affect accuracy? Ann Surg Oncol 2011;18:3149–3154.

27.Bhargava R, Dabbs DJ, Beriwal S, Yildiz IA, Badve P, Soran A, Johnson RR, Brufsky AM, Lembersky BC, McGuire KP, Ahrendt GM. Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer. Mod Pathol. 2010 Nov19.

28.Dirican A, Andacoglu O, Johnson R, McGuire K, Mager L, Soran A. The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Support Care Cancer. 2010 May6.

29.McGuire, KP, Santillan, A, Kaur, P, Meade, T, Parbhoo, J, Mathias, M, Shamehdi, C, Davis, M, Ramos, D, Cox, CE. Mastectomy vs breast conservation: Mastectomy on the rise. American Journal of Hematology/Oncology. January 2010;9(1).

30.McGuire, KP, Eisen, S, Rodriguez, A, Meade, T, Cox, CE, Khakpour, N. Factors Associated with Improved Outcome after Mastectomy in Metastatic Breast Cancer. The American Journal of Surgery 2009; 198:511–515

31.McGuire, KP, Lee, MC, Laronga, C. Contralateral Mastectomy in Patients Treated for Unilateral Breast Cancer. Current Breast Cancer Reports 2009,1:104–109.

32.Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009Dec; 209(6):746-52.

33.McGuire, KP, Santillan, A, Kaur, P, Meade, T, Parbhoo, J, Mathias, M, Shamehdi, C, Davis, M, Ramos, D, Cox, CE. Are mastectomies on the rise? A 13 year trend analysis of the selection of mastectomy vs. Breast Conservation Therapy in 5865 patients. Ann Surg Oncol. 2009 Oct; 16(10):2682-90.

34.McGuire, KP, Laronga, C. Commentary on Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. Breast Diseases Quarterly 20(2); July-September 2009;182-183.

35.Morris GJ, Berger AC, Emanuelson RG, Jordan WE 3rd, McGuire K, Thomas LC. Breast cancer with positive sentinel lymph node: now what? Semin Oncol. 2009 Apr;36(2):84-9.

36.Kairys, JC, McGuire, K, Crawford, AG, Yeo, CJ. Cumulative operative experience is decreasing during general surgery residency: A worrisome trend for surgical trainees? Journal of the American College of Surgeons. 2008 May; 2006(5):804-11; discussion811-3.

37.Rosenberg, LM, Golesorkhi, N, McGuire, K, Kennedy, EP, Yeo, C, Rosato, E. Groove Pancreatitis: A Case Series. Journal of Surgical Research. 2008 February; 144 (2):373.

38.McGuire,K,Rosenberg,A,Brill,K,Showalter,S,Flynn,A,Copit,S.Timingofsentinellymph node biopsy and reconstruction for patients undergoing mastectomy. Annals of Plastic Surgery. 59(4):359-363, October2007.

39.Lanza-Jacoby, S, Burd, R, Rosato, FE Jr., McGuire, KP, Little, J, Ngoubilly, N, Miller, S. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in Her2/neu positive breast cancer. Clinical Cancer Research. 2006 October 15; 12 (20 pt 1):6161-9.

40.McGuire, KP, Ngoubilly, N, Neavyn, M, Lanza-Jacoby, S. 3,3’ – diindolylmethane and paclitaxel act synergistically to promote apoptosis in Her2-neu human breast cancer cells. Journal of Surgical Research. 2006 May 15; 132(2):208-13.

Refereed Papers/Article In Press/Submitted

1. Reddy, KG, Strassle, PD, McGuire, KP. The Role of Age, Tumor Biology, and Radiation Therapy on Post-Mastectomy Reconstruction. Clinical Breast Cancer. Submitted for publication.

Scientific Abstracts/Poster Presentations/Plenary Presentations:

  1. Carr, J, Meng, K, Baggett, C, McGuire, KP. Age Disparity Exists in the Use of Neoadjuvant Chemotherapy for Breast Cancer. Society of Surgical Oncology, 70th Annual Cancer Symposium, March 15-18,2017.
  2. Reddy, KG, Strassle, P, McGuire, KP. Post Mastectomy Reconstruction Rates:The Effect of Tumor Grade and Radiation Therapy in Younger Women. 12th Annual Academic Surgical Congress, February 8,2017.
  3. Reddy, KG, Strassle, P, McGuire, KP. Post-mastectomy reconstruction rates: Does tumor biology and radiation therapy have a greater effect in younger women? 1st Annual Resident Research Day, May 5, 2016 (Distinguished PosterPresentation).
  4. White, AM, McAuliffe, PF, Thomas, C, Ahrent, GM, Bonaventura, M, DeLaCruz, C, Diego, E, Gimbel, M, Johnson, R, Nguyen, V, Shestak, K, Soran, A, McGuire, KP. Local Recurrence and Cosmesis in Breast Conserving Surgery Compared to Total Mastectomy and Nipple Sparing Mastectomy. 11th Annual Academic Surgical Congress, February 2-4,2016.
  5. McAuliffe PF, Brown DD, Oesterreich S, Lee AV, Johnson RR, McGuire KP, et al. Developing in vitro models of ductal carcinoma in situ from primary tissue. 38th Annual San Antonio Breast Cancer Symposium, December 8-12,2015.
  6. Soran A, Johnson R, Menekse E, Bhargava R, McGuire K, et al. Prediction of response to neoadjuvant chemotherapy in ER+ breast cancer: Magee equation recurrence versus Oncotype DX® recurrence score. 38th Annual San Antonio Breast Cancer Symposium, December 8-12, 2015.
  7. De Los Santos J, Hyslop T, Alvarado M, Forero A, Golshan M, Hieken T, Horton J, Hudis C, McGuire K, et al. Treatment outcomes in patients with invasive breast cancer treated by neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis ofTBCRC

017. 38th Annual San Antonio Breast Cancer Symposium, December 8-12, 2015.

  1. Soran, A, Menekse, E, McKolanis, J, McAuliffe, PF, McGuire, KP, et al. Is nipple aspirate fluid (NAF) a reliable source to identify biomarkers in breast cancer? A feasibility study. 2015 American Society of Clinical Oncology. American Society of Clinical Oncology Annual 2015 Meeting, May 29-June 2,2015.
  2. Grahovac, T, Soran, A, Thomas, C, McAuliffe, PF, Diego, E, Bonaventura, M, Johnson, R, Ahrendt, GM, McGuire, KP. Margin Width is Not Predictive of Residual Disease on Re-excision in Breast Conserving Surgery After Neoadjuvant Chemotherapy. American Society of Breast Surgery 16th Annual Meeting, April 29-May 3,2015.
  3. Grahovac, T, McGuire, KP, Soran, A, Thomas, C, McAuliffe, PF, Diego, E, Bonaventura, M, Johnson, R, Ahrendt, GM. Radioactive Seed Localization in Breast Cancer Patients Treated with Neoadjuvant Therapy: A Safe and Effective Alternative to Wires. Society of Surgical Oncology 68th Annual Cancer Symposium, March 25-28,2015.
  4. Diego, E, McAuliffe, P, McGuire, KP, Bonaventura, M, Soran, A, Johnson, R, Ahrendt, GM. Axillary Staging after Neoadjuvant Chemotherapy (NAC) for Breast Cancer (BC): A Pilot Study Combining Sentinel Lymph Node Biopsy (SLB) with Radioactive Seed Localization (RSL) ofPre-

treatment Positive Axillary Lymph Nodes (LN+). Society of Surgical Oncology 68th Annual Cancer Symposium, March 25-28, 2015.

  1. Chen, AW, Hakim, C, Soran, A, Ahrendt, GM, Diego, EJ, Bonaventura, M, Johnson, R, Armstrong, M, Carty, SE, Stang, MT, McGuire, KP, McAuliffe, PF. Does the Axillary Approach for Robotic Thyroidectomy Affect Subsequent Breast Screening and/or Axillary Staging? Society of Surgical Oncology 68th Annual Cancer Symposium, March 25-28,2015.
  2. Zamanian, M, Soran, A, Wright, M, Thomas, C. McGuire, KP. Differences in Tumor Presentation and Treatment Between Pre and Post-menopausal Patients with Invasive Lobular Carcinoma. 10th Annual Academic Surgical Congress, February 3-5.2015.
  3. Wright, M, Soran, A., Zamanian, M, Thomas, C. McGuire, KP. Breast Density, BMI and Outcomes in Premenopausal Women with Breast Cancer. 10th Annual Academic Surgical Congress, February 3-5.2015.
  4. Pahuja S, McGuire K, Davidson N, Brufsky A, Rastogi P, Jankowitz R, Lembersky B, Puhalla S. Response to subsequent therapies after failure to achieve pathologic complete response (pCR) after neo-adjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). 37th Annual San Antonio Breast Cancer Symposium, December 9-13,2014.
  5. Diego E, McAuliffe P, Soran A, McGuire KP, Costellic C, Bonaventura M, Johnson R, Ahrendt GM. For High-Risk Lesions, Excisional Breast Biopsy Specimen Volume Is Reduced in Radioactive Seed Localization vs Needle Localization With No Change in Operative Time or Upstage Rate. American Society of Breast Surgeons, 15th Annual Symposium, April 30-May 4, 2014 (OralPresentation).
  6. Diego E, McAuliffe P, McGuire KP, Soran A, Hinton J, Herstine J, Johnson R, Bonaventura M. Telemedicine for Delivery of Specialized Breast Care in Rural Areas: A Pilot Study. American Society of Breast Surgeons, 15th Annual Symposium, April 30-May 4,2014.
  7. Steiman J, Soran A, McAuliffe P, Diego E, Bonaventura M, Johnson R, Ahrendt G, McGuire, KP. Omission of Sentinel Lymph Node Biopsy (SLNB) Does Not Alter Recurrence or Survival in Estrogen Receptor (ER)+ Early-Stage Breast Cancer in Women 80 Years and Older. American Society of Breast Surgeons, 15th Annual Symposium, April 30-May 4,2014.
  8. Soran, A, Degore, A, McGuire, K, Groen-Mager, L, Johnson, R. The importance of detection subclinical breast cancer-related lymphedema after axillary lymph node dissection; prospective observational study. 24th Annual Interdisciplinary Breast Center Conference, March 15-19,2014.
  9. Steiman J, Soran A, McGuire KP, McAuliffe P, Diego E, Bonaventura M, Johnson R, Ahrendt G. Pathologic Nodal Stage (pN) is Superior to Lymph Node Ratio(LNR) as a Predictor of Recurrence and Survival in Persistently Node-positive Breast Cancer following Neoadjuvant Chemotherapy (NAC). Society of Surgical Oncology 67th Annual Cancer Symposium, March 12- 15,2014.
  10. Steiman J, Soran A, McAuliffe P, Diego E, Bonaventura M, Johnson R, Ahrendt G, McGuire, KP. Predictive Value of Axillary Nodal Imaging following Neoadjuvant Chemotherapy. Society of Surgical Oncology 67th Annual Cancer Symposium, March 12-15,2014.
  11. Liao G, Hartmaier RJ, Luthra S, Chandran U, McGuire KP, Puhalla SL, Lee AV, Tseng GC, Oesterreich S. Unique genetic, epigenetic, and transcriptomic changes in premenopausal breast cancer suggest novel strategies for therapy. 36th Annual San Antonio Breast Cancer Symposium, December 10-14,2013.
  12. King TA, Lyman JP, Gonen M, Voci A, Boafo C, Hwang ES, Rugo HS, Alvarado M, Liu M, Boughey JC, Jacobs LK, Krontiras H, McGuire K, et al. TBCRC 013: A prospective analysis of the role of surgery in stage IV breast cancer. 36th Annual San Antonio Breast Cancer Symposium, December 10-14,2013.
  13. Fackler MJ, Bujanda ZL, Umbricht C, Teo WW, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Ingle JN, Boughey J, McGuire K, et al. cMethDNA is a quantitativecirculating

methylated DNA assay for detection of metastatic breast cancer and for monitoring response to therapy. 36th Annual San Antonio Breast Cancer Symposium, December 10-14, 2013.

  1. McGuire KP, De Los Santos JF, Cantor A, Forero A, Golshan M, Meric-Bernstam F, Horton JK, Amos KD, Hudis CA, Hylton NM, Meszoely IM, Nanda R, Hwang ES. Nodal patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy: Results of a secondary analysis of TBCRC 017. 36th Annual San Antonio Breast Cancer Symposium, December 10-14,2013.
  2. Soran, A, McGuire, KP, Ahrendt, G, Bonaventura, M, McAuliffe, PF, Diego, E, Johnson, R. The Impact of Recurrence Score (RS) on Pre-Treatment Core Biopsies in Predicting Response to Neoadjuvant Chemotherapy (NCT) in Patients (pts) with ER+ Breast Cancer (BC). American Society of Clinical Oncology Breast Cancer Symposium 2013, September 9,2013.
  3. Hadzikadic Gusic, L; Falcone, J; McGuireKP.; Soran, A; Diego, EJ; Thomas, CR.; McAuliffe, PF; Bonaventura, M; Johnson, RR.; Ahrendt, GM. Surgery in Metastatic Breast Cancer: Is Improved Outcome Due to Selection Bias? American Society of Clinical Oncology Annual 2013 Meeting, May 31-June 4,2013.
  4. King, TA, Lyman, JP, Gonen, M, Voci, A, De Brot, M, Boafa, C, Sing, AP, Hwang, ES, Alvarado, M, Liu, MC, Boughey, JC, McGuire, KP, et al., Translational Breast Cancer Research Consortium .Prognostic impact of the 21-gene recurrence score in patients presenting with stage IV breast cancer. American Society of Clinical Oncology Annual 2013 Meeting May 31-June 4, 2013. (Oralpresentation)
  5. Soran, A, DeGore, L, McGuire, KP, Bonaventura, M, McAuliffe, PF, Diego, E, Ahrendt, GM, Johnson, R. The efficacy of subclinical lymphedema detection in high-risk breast cancer survivors. American Society of Clinical Oncology Annual 2013 Meeting, May 31-June 4,2013.
  6. Hadzikadic Gusic, L; McGuireKP. Ozmen, T; Soran, A; Diego, EJ; Thomas, CR.; McAuliffe, PF; Bonaventura, M; Johnson, RR.; Ahrendt, GM. Margin Width is Not Predictive of Residual Disease on Re-excision in Breast Conserving Therapy. American Society of Breast Surgeons, 14th Annual Symposium, May 1-5,2013.
  7. Sharek, D, Zuley, M, Zhang, Y, Ahrendt, G, Soran, A, McGuire, K. Comparison of the Surgical Outcomes Between Wire Localization and Radioactive Seed Localization for Segmental Mastectomies. To compare radioactive seed localization (RSL) to wire localization (WL) for surgical margin status, specimen size, and re-excision. American Roentgen Ray Society, 113th Annual Meeting, April 14-19, 2013. (Oralpresentation)
  8. Jankowitz, R, McGuire, KP, Davidson, N. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer. 13th International St .Gallen–Breast Cancer Conference, March 13-16, 2013. (Oralpresentation)
  9. McAuliffe, PF, McGuire, KP, Diego, EJ, Soran, A, Puhalla, SL, Lembersky, BC, Puleio, DV, Spangler, ML, Berg, WA, Beriwal, S, Bhargava, R, Gimbel, ML, Goldstein, SL, Engel, GS, Bonaventura, M, Ahrendt, GM, Johnson, RR. Teleconferencing for Breast Cancer Multidisciplinary Conference. 66th Annual Cancer Symposium of the Society of Surgical Oncology, March 6-9th,2013.
  10. Kaminsky, A, Bhargava, R, McGuire, KP, Puhalla, S; Single institution experience with neoadjuvant chemotherapy for metaplastic breast cancer (MBC).American Society of Clinical Oncology, 12th Annual Meeting, June 1-5,2012.
  11. Diego, E; McGuire, KP; Soran, A; Kanbour, M; Bonaventura, M; Johnson, R, Ahrendt, GM. Factors that Affect a Patient’s Decision to Undergo Contralateral Prophylactic Mastectomy: Is Neoadjuvant Chemotherapy One of Them? The American Society of Breast Surgeons, 13th Annual Meeting, May 2-6,2012.
  12. Kamali Polat, AD; Veysel Polat, A; Andacoglu, O; McGuire, K; Diego, E; Johnson, R. The Importance of Pre-operative Needle Core Breast Biopsy results on Cosmetic Outcome inBreast